SMAD-signaling inhibition: potential for developing newer treatments for corneal fibrosis [abstract]

MOspace/Manakin Repository

Breadcrumbs Navigation

SMAD-signaling inhibition: potential for developing newer treatments for corneal fibrosis [abstract]

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/9414

[+] show full item record


Title: SMAD-signaling inhibition: potential for developing newer treatments for corneal fibrosis [abstract]
Author: Gupta, Rangan, 1978-; Tandon, Ashish; Tovey, Jonathan; Sharma, Ajay
Keywords: myofibroblasts
anti-fibrotic therapies
Date: 2010-11-11
Abstract: Transforming growth factor β (TGFb) is known to cause fibrosis in the cornea following injury and/or infection. Effective reduction in corneal fibrosis has been reported by inhibiting TGFb activity. However, associated molecular mechanism is still unknown. The aim of study was to test the hypothesis that the alteration in SMAD signaling is a novel approach for treating corneal fibrosis using an established in vitro model.
URI: http://hdl.handle.net/10355/9414

This item appears in the following Collection(s)

[+] show full item record